On successful completion of this activity one should be able to judge the prognosis of patients harboring metastasized differentiated thyroid cancer (DTC); identify suitable treatment regimens, taking into account the characteristics of the tumor and the patient's general condition; and know the basics of radioiodine treatment, tyrosine kinase treatment, and redifferentiation treatment for metastasized DTC.
Keywords: metastasized thyroid cancer; radioiodine refractory thyroid cancer; redifferentiation; tyrosine kinase inhibitor.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.